Trials / Completed
CompletedNCT05884099
Intercostal Cryoanalgesia for Chronic Pain After VATS Lung Resection
Intercostal Cryoanalgesia for Prevention of Chronic Postoperative Pain Following Video-assisted Thoracoscopic Lung Cancer Resection
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM) · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Intercostal cryoanalgesia is a technique that allows extensive and prolonged analgesia of the hemithorax. The aim of this study is to demonstrate the efficacy of intercostal cryoanalgesia as an adjunct to a single-injection paravertebral block for the prevention of chronic thoracic pain after VATS lung resection surgery.
Detailed description
VATS lung resection is associated with a high incidence of persistent thoracic pain. To our knowledge, there is no study on the effect of cryoanalgesia on the incidence and severity of chronic thoracic pain 3 months after VATS lung resection. Intercostal cryoanalgesia is a technique that allows extensive and prolonged analgesia of the hemithorax. In a recent study by Ilfeld \& al, intercostal cryoanalgesia (combined with a single-injection paravertebral block) was able to drastically lower the incidence of chronic pain after total mastectomy compared to the use of the paravertebral block alone (3% vs 17%). The aim of this study is to demonstrate the efficacy of intercostal cryoanalgesia for the prevention of chronic thoracic pain after VATS lung resection surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cryoanalgesia AND single-injection paravertebral block | CO2 Cryoanalgesia AND paravertebral block with Bupivacaine 0.5% |
| PROCEDURE | Single-injection paravertebral block | Paravertebral block with Bupivacaine 0.5% |
Timeline
- Start date
- 2023-11-09
- Primary completion
- 2025-01-21
- Completion
- 2025-04-21
- First posted
- 2023-06-01
- Last updated
- 2025-07-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05884099. Inclusion in this directory is not an endorsement.